SOHO 2025 | CML in low- and middle-income countries: exploring the feasibility of treatment-free remissions
In this video, Pat Garcia-Gonzalez, CEO of The Max Foundation, Seattle, WA, shares insights from over two decades of work providing access to TKI therapy for patients with chronic myeloid leukemia (CML) in low- and middle-income countries. Ms Garcia-Gonzalez highlights the success of their 22-year experience in providing access to TKIs to 100,000 patients. She then presents promising results from a pilot program exploring treatment-free remission (TFR), showing it to be a safe and feasible option in resource-limited settings. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
